Proving her illness created an illusion of wellness for columnist Ahna Crum, but a relapse after nine years showed her she ...
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosisParis, December 24, 2025.
Fear of relapse and worsening disease is common for MS patients, leading to poorer mental health, per a study calling for ...
"Weight reducing or anti-obesity drugs, currently available, ought to be used very judiciously," the Minister said while addressing the inaugural session of the 2-day "Asia Oceania Conference on ...
HOUSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...
Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial We analyzed electronic health record data of ...